Inventor

VILLANI FRANK J

US34 patents

⚠️ This page may combine multiple inventors who share the name “VILLANI FRANK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VILLANI FRANK J

SCHERING CORP

Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies

Antihistaminic 8-(halo)-substituted 6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridines

6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use

Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use

Tricyclic-substituted piperidine antihistamines

Tricyclic-substituted piperidine antihistamines

Tricyclic derivatives, compositions and methods of use

Benzo(5,6)cycloheptapyridines, compositions and methods of use

Tricyclic antihistamines

Tricyclic antihistamines

JANSSEN PHARMACEUTICA NV

Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

Process for the preparation of substituted-1,2,3,4-tetrahydroisoquinoline derivatives

Sulfamide derivative useful for the treatment of epilepsy

Compounds having inhibitory activity against sodium-dependent glucose transporter

Substituted pyridyl amide compounds as modulators of the histamine H3 receptor

Substituted pyridyl amide compounds as modulators of the histamine H3 receptor

Substituted pyridyl amide compounds as modulators of the histamine H3 receptor

Process for the preparation of protected L-alanine derivatives

Process for the preparation of protected L-alanine derivatives

Process for the preparation of chymase modulators

FURIEX PHARMACEUTICALS INC

Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl—1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

Crystals and process of making 5-({(2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(-4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

ANZALONE LUIGI

Process for the preparation of protected L-alanine derivatives

Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

Process for the preparation of chymase modulators

ORTHO PHARMA CORP

Liquid phase peptide synthesis of KL-4 pulmonary surfactant

Liquid phase peptide syntheses of KL-4 pulmonary surfactant

FOREST TOSARA LTD

Crystals and process of making 5-({[2-amino-3-(4-Carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

ALLERGAN HOLDINGS UNLIMITED COMPANY

Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

KEITH JOHN M

Substituted pyridyl amide compounds as modulators of the histamine H3 receptor

MCNEILAB INC

Tramadol n-oxide material, enantiomers and compositions thereof, and their use

ABDEL-MAGID AHMED F

Liquid phase peptide synthesis of KL-4 pulmonary surfactant

MEHRMAN STEVEN J

Salts of 3-(3-amino-2-(R)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one